共 54 条
[1]
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
[J].
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM,
2009, 296 (03)
:E415-E421
[2]
[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1
[3]
[Anonymous], SCI REP UK
[4]
[Anonymous], YOG PLAIN WHOL MILK
[5]
[Anonymous], 2017, IDF DIABETES ATLAS
[8]
Chakrabarti R, 2002, CURR SCI INDIA, V83, P1533
[10]
Chen WeiJun Chen WeiJun, 2006, Acta Nutrimenta Sinica, V28, P221